The pharmacokinetics of intravenous salbutamol in pediatric status asthmaticus: a pilot study.

Completed

• Conditions: acute severe asthma; status asthmaticus; 10006436

• Registration Number: NL-OMON37955
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 20

Inclusion Criteria

Age 0 to 18 years-admitted to the hospital because of status asthmaticus- Need for continuous salbutamol nebulisation (more than 3 times/ hour)- Patient/parental informed consent

Exclusion Criteria

- Withdrawal of informed consent

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The main study parameter is the description of the pharmacokinetic parameters<br /><br>of intravenous salbutamol.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary study parameters are the efficacy (asthma scores) and safety<br /><br>(occurrence of side-effects) of intravenous salbutamol.</p><br>